Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuriko Fueki"'
Autor:
Utako Seino, Yuji Hirowatari, Mika Kon, Takashi Miida, Yuki Horiuchi, Shin Goto, Yuriko Fueki, Hiroki Maruyama, Satoshi Hirayama, Tsuyoshi Ueno, Yoshifumi Fukushima, Hirotoshi Ohmura, Noriaki Iino, Mayumi Idei
Publikováno v:
Clinica Chimica Acta. 411:1723-1727
Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) often have inflammation and dyslipidemia that accelerate to atherosclerosis. This study aimed to evaluate chronic inflammation and dyslipidemia in CAPD patients.We measured inflamma
Autor:
Masahiko Okada, Masayuki Ito, Hitoshi Hama, Elfi Wardaningsih, Osamu Hanyu, Akiko Tsuda, Takashi Miida, Yuriko Fueki, Akihiro Takahashi, Hisashi Saito, Akira Nakamura
Publikováno v:
Clinica Chimica Acta. 382:71-76
There is a great deal of controversy surrounding the relationship between alcohol consumption and insulin resistance. This association may be further confounded by the presence of obesity. We aimed to clarify whether regular alcohol consumption impro
Autor:
Utako Seino, Keiichiro Kosuge, Satoshi Soda, Yuriko Fueki, Akihiro Takahashi, Osamu Hanyu, Masahiko Okada, Toshiyuki Yamada, Masayuki Ito, Konen Obayashi, Takashi Miida, Osamu Miyazaki
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761:424-433
Inflammation is a risk factor for Alzheimer's disease. Serum amyloid A (SAA) is an acute phase protein that dissociates apolipoprotein AI (apoAI) from plasma HDL. In cerebrospinal fluid (CSF), the SAA concentration is much higher in subjects with Alz
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 11:190-199
Despite a long history of studies on lipid abnormalities, numerous problems in laboratory technologies and techniques remain unresolved. One of the most commonly tested molecules is low-density lipoprotein (LDL) cholesterol, and a homogenous assay te
Autor:
Masayuki Ito, Takashi Miida, Yutaka Ogura, Yuriko Fueki, Yuji Hirowatari, Hiroshi Yoshida, Nobuyuki Sakurai
Publikováno v:
Annals of clinical biochemistry. 45(Pt 6)
BackgroundIncreased triglyceride (TG)-rich lipoproteins and decreased HDL that are implicated in the progression of atherosclerotic vascular diseases, are present in serum samples of patients undergoing haemodialysis (HD) therapy. Therefore, it is im
Autor:
Yoshifusa Aizawa, Takashi Miida, Elfi Wardaningsih, Takako Ito, Konen Obayashi, Satoshi Soda, Osamu Hanyu, Satoshi Hirayama, Keiichiro Kosuge, Yuriko Fueki
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 384(1-2)
Lipoprotein lipase (LPL) is a key enzyme in the metabolism of triglyceride (TG)-rich lipoproteins. LPL in the preheparin serum (Pr-LPL) mass reflects the insulin sensitivity of diabetic patients (DM) receiving neither insulin nor hypoglycemic agents.